Furthermore, blocking ROR1 could significantly reduce the expression of p-STAT3 and c-Myc, while the overexpression of ROR1 has the opposite effect, indicating that artesunate could downregulate the STAT3/c-Myc pathway by reducing ROR1 in NSCLC cell lines [27]. The gene discussed is STAT3; the disease is non-small cell lung carcinoma.